Windtree Therapeutics Inc
Company Profile
Business description
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
Contact
2600 Kelly Road
Suite 100
Warrington PA 18976-3622
USAT: +1 215 488-9300
E: ir@discoverylabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
20
Stocks News & Analysis
stocks
Going into earnings, Is Apple stock a buy, a sell, or fairly valued?
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,153.40 | 59.10 | 0.73% |
| CAC 40 | 7,517.68 | 90.66 | 1.22% |
| DAX 40 | 18,417.55 | 118.83 | 0.65% |
| Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
| FTSE 100 | 8,285.71 | 99.36 | 1.21% |
| HKSE | 17,021.31 | 16.34 | 0.10% |
| NASDAQ | 17,357.88 | 176.16 | 1.03% |
| Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
| NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
| S&P 500 | 5,459.10 | 59.88 | 1.11% |
| S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
| SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
| Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
| Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
| Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
| Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
| Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
| South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
| Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |